Study outcomes in people with inflammatory bowel disease
Part of Digestive system clinical trials.
This study looks at what factors help predict how inflammatory bowel disease (IBD) may progress over time. You may be able to join if you are an adult with IBD and fit one of the study groups based on whether you have used TNF-blocking medicines before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- You have inflammatory bowel disease (IBD) OR you may be in the comparison group without colitis
- If you have IBD, you are either new to TNF-α inhibitor medicines or currently taking them
- Do not have a past history of TNF-α inhibitor treatment if you are in the “TNF-α inhibitor-naive” group
- In the non-IBD comparison group, you should not have colitis, cancer, or advanced colon polyps (e.g., many polyps, large polyps, or high-risk types)
- Do not have taken antibiotics or probiotics in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the lining of the colon heals in people with inflammatory bowel disease (ulcerative colitis or Crohn’s disease). It may help researchers understand whether anti-TNF treatment improves healing, especially when people have limited prior response or are starting biologic therapy.
This study looks at blood and/or tissue “molecular” (cell-level) reasons why treatments don’t fully work in adults with Crohn’s disease or ulcerative colitis. If you are starting a biologic or small-molecule medicine and still have moderate to severe symptoms, you may be able to contribute to research that helps improve future care.
This study is looking at how the immune system works in people with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. By comparing blood or tissue samples from people with and without IBD, researchers hope to find better ways to treat the disease in the future.
This study looks at people with inflammatory bowel disease (Crohn’s disease or ulcerative colitis) and compares them with people without it. Researchers want to understand differences that may help explain or better detect the disease.
This study collects blood and tissue samples to better understand how the immune system behaves in people with inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It aims to advance research rather than test a specific new treatment, and it also enrolls healthy volunteers for comparison.
This study looks at immune system changes in people around the time inflammatory bowel disease (IBD) is first diagnosed, and compares different groups (new, very recent, or not found on scope). It may help researchers understand what the immune system looks like early in IBD and later in people who don’t show it on colonoscopy.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.